16.11.2015
- Mylan’s seven month-long, $26 billion long-shot hostile bid for Perrigo has ended in defeat for the Netherlands-based drugmaker. By the target deadline of Friday, Nov. 13, only 40%...
30.10.2015
- US pharmaceutical giant Pfizer and Ireland-domiciled former US drugmaker Allergan (in its current incarnation a combined Allergan and Actavis) have confirmed they are in “friendly”...
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
10.09.2015
- Mylan has announced a fresh $27.14 billion offer for generic drug and ingredients maker Perrigo. The Ireland-based drugmaker previously rejected several offers from its Netherlands...
30.07.2015
- July this year began with the highest-ever value of M&A transactions announced in any July since 2008, says Mergermarket, an independent Mergers and Acquisitions (M&A) intelligence...
30.07.2015
- In the latest spectacular takeover to occupy the attention of the international pharmaceuticals sector, Israeli generics giant Teva has agreed to pay $40.5 billion cash and stock...
18.06.2015
- The newly merged Allergan – as generics drugmaker Actavis rebranded itself following the takeover of Allergan – has announced it is acquiring Kythera Biopharmaceuticals for $2.1...
15.06.2015
- Following shareholder approval of the name change on Jun 5, Iceland-based generic drugmaker Actavis has begun trading as Allergan. The name change follows the Botox manufacturer’s...
